GOLETA, CA – Medtrade exhibitor Inogen, a medical technology company offering respiratory products for use in the homecare setting, has appointed Kevin P. Smith as general counsel and executive vice president, Business Development, effective July 22, 2024. Smith joins Inogen from Sirtex Medical, where he served as general counsel and executive vice president, Business Development, since 2018.

Smith brings nearly 30 years of experience to the Company. Prior to joining Sirtex, Smith served as vice president and associate general counsel at Flexion Therapeutics, focusing on securities requirements, business development, and intellectual property. Previously, he was general counsel for the Danaher Life Sciences Platform.

“Kevin will be an invaluable addition to our leadership team at Inogen,” said Kevin Smith, president and CEO of Inogen. “His extensive experience in the medical device and securities field will play an important role in strengthening our legal team and ensuring Inogen remains an organization based on integrity and compliance.”